Type I interferon drives T cell responses to amyloid beta in the central nervous system

Amyloid beta (Aβ) plaque deposition in the central nervous system (CNS) is a hallmark of Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA), triggering robust innate immune responses. However, the role of the adaptive immune system remains less well understood. Here we show the immune mi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Michel, Julius (Auteur) , Sanghvi, Khwab (Auteur) , Rosenbauer, Jakob (Auteur) , Humbs, Lea (Auteur) , Tejido Dierrsen, Clara (Auteur) , Grudzenski-Theis, Saskia (Auteur) , Sachs, Viktoria (Auteur) , Jähne, Kristine (Auteur) , Degenhardt, Karoline (Auteur) , Frölich, Lutz (Auteur) , Herms, Jochen (Auteur) , Fatar, Marc (Auteur) , Platten, Michael (Auteur) , Bunse, Lukas (Auteur)
Format: Article (Journal)
Langue:anglais
Publié: 23 April 2026
In: Nature Communications
Year: 2026, Volume: 17, Pages: 1-17
ISSN:2041-1723
DOI:10.1038/s41467-026-72262-6
Accès en ligne:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41467-026-72262-6
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41467-026-72262-6
Accéder au texte intégral
Notes sur l'auteur:Julius J. Michel, Khwab Sanghvi, Jakob Rosenbauer, Lea Humbs, Clara Tejido Dierssen, Saskia Grudzenski-Theis, Viktoria Sachs, Kristine Jähne, Karoline Degenhardt, Lutz Frölich, Jochen Herms, Marc Fatar, Michael Platten & Lukas Bunse
Description
Résumé:Amyloid beta (Aβ) plaque deposition in the central nervous system (CNS) is a hallmark of Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA), triggering robust innate immune responses. However, the role of the adaptive immune system remains less well understood. Here we show the immune microenvironment dynamics in APP23 transgenic (APP23-tg) mice modelling CNS amyloid pathology, using single-cell transcriptomics. We observed a marked increase in T-cell populations during late disease stages, particularly CD8⁺ T-cells that clustered around Aβ plaques, suggesting a targeted immune response. Among these, we identified an Aβ plaque-associated subset of CD8⁺ T cells expressing interferon-stimulated genes (ISGs), which promoted Type-I interferon signaling. This subset also produced CXCL10, facilitating the recruitment of non-ISG T cells through the CXCL10-CXCR3 axis. Importantly, similar Type-I interferon responses were detected near plaques in human CNS amyloid pathology. Together, these findings highlight a shift from microglia-driven to T-cell-mediated neuroinflammation as amyloid pathology progresses, with implications for time-resolved therapy development.
Description:Gesehen am 21.05.2026
Description matérielle:Online Resource
ISSN:2041-1723
DOI:10.1038/s41467-026-72262-6